Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-Pump for Post-Bariatric Hypoglycemia
NCT02733588Phase 2Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in post-bariatric hypoglycemia (PBH), sponsored by Xeris Biopharma Holdings, Inc.. Started Mar 2016; status: completed.
02
Drugs
glucagon
03
Conditions
post-bariatric hypoglycemia (PBH)
Beyond the preview
Go deeper on NCT02733588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733588.